Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 Big Reasons Exelixis, Inc. Soared 22% in January
2 Big Reasons Exelixis, Inc. Soared 22% in January
2 Big Reasons Exelixis, Inc. Soared 22% in January
Submitted by
admin
on February 2, 2017 - 9:17am
Source:
Motley Fool
News Tags:
Exelixis
Cotellic
Roche
cabozantinib
Takeda
Headline:
2 Big Reasons Exelixis, Inc. Soared 22% in January
Do Not Allow Advertisers to Use My Personal information
